Industry

DUBLIN–(BUSINESS WIRE)–The “Global Medical Imaging Informatics Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Type, Application, and Components” report has been added to ResearchAndMarkets.com’s offering. The global medical imaging informatics market is expected to grow from US$ 3,671.72 million in 2021 to US$ 5,175.39 million by 2028; it is estimated to grow … [Read more…]

– State-of-the-art laboratory space will become available in 2025 – New building will bring SmartLabs to its third city in the United States BOSTON–(BUSINESS WIRE)–Capitalizing on Philadelphia’s emergence as a national hub for cell and gene therapy, SmartLabs, a Boston-based Laboratory-as-a-Service (LaaS) leader, today announced plans to open its first facility in the city in … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Hospital-Acquired Disease Testing Market Analysis by Test Type (Pneumonia Stents, Urinary Tract Infection, Blood Stream Infection, Surgical Site Infection, Methicillin-Resistant Staphylococcus Aureus), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global hospital-acquired disease testing market size is estimated to be USD 1,500.4 million in 2021 and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “TNF Alpha Inhibitors Global Market Report 2022: By Drug, By Route, By Disease” report has been added to ResearchAndMarkets.com’s offering. The global TNF Alpha Inhibitors market is expected to grow from $38.56 billion in 2021 to $40.73 billion in 2022 at a compound annual growth rate (CAGR) of 5.6%. The market is expected … [Read more…]

Innovation awards announced at 2022 Microscopy & Microanalysis Meeting, Portland, Oregon, 31st July – 4th August, 2022 ROME–(BUSINESS WIRE)–CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, has been recognised as developing one of the ten best microscopy innovations in the 2022 Microscopy Today Innovation Awards, DeepSIM. … [Read more…]

RWS’s Life Sciences team will work with consortium members to drive innovation, best practice and adoption of eCOA within clinical trials CHALFONT ST PETER, England–(BUSINESS WIRE)–RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property services, today announces that it has joined Critical Path Institute’s Electronic Clinical Outcome Assessment (eCOA) Consortium to help … [Read more…]

MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that a planned futility interim analysis of the INTERLINK-1 Phase 3 study sponsored by AstraZeneca (LSE/STO/Nasdaq: AZN) did not meet a pre-defined threshold for efficacy. Based on this result and the recommendation of an Independent Data Monitoring … [Read more…]

Multi-year collaboration will sustain Ipsen’s presence in oncology by leveraging Marengo’s novel discovery of TCR Vβ-targeted precision T cell activation approach Ipsen to pay Marengo $45 million upfront with potential for additional milestone payments PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) and Marengo Therapeutics, Inc. today announced a strategic partnership to … [Read more…]

Positive results show Pentarlandir is safe and effective in patients with mild-to-moderate COVID-19 LOS ANGELES & NEW TAIPEI CITY, Taiwan–(BUSINESS WIRE)–SyneuRx™ International (TPEX:6575), a global biotech company focused on the development of new classes of drugs for COVID-19 and multiple major central nervous system disorders, today announced results from its phase 2 clinical trial evaluating … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–#AAIC2022–Data released from C2N Diagnostics, presented today at the Alzheimer’s Association International Conference, demonstrated that a blood test combining the Aβ42/40 ratio, a component of C2N’s commercially available PrecivityADTM blood test, with a unique p-tau217 ratio leads to testing performance that points to accuracy comparable to more complex amyloid PET imaging and invasive … [Read more…]